Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

PRODIGIO · PROton therapy DIfferentiable Gradient-based Inverse Optimization

HORIZONStatus: SIGNED1 November 202631 October 2028EU funding €194,075Call HORIZON-MSCA-2025-PF

PRODIGIO (PROton therapy DIfferentiable Gradient-based Inverse Optimization) aims to develop the first uncertainty-aware auto-planning framework for Intensity-Modulated Proton Therapy (IMPT).This project addresses a critical gap in current treatment planning systems, which optimise only beam fluences while keeping orientations and energy layers fixed and manually chosen by the operator, and account for uncertainties through simplistic global margins. These limitations restrict plan quality, increase computation times, and lead to strong operator dependence.At its core, PRODIGIO will develop a deep-learning dose engine trained on Monte Carlo simulations, capable of producing millisecond-accurate dose maps. Differentiable estimates of motion- and density-related uncertainties will be incorporated using advanced methods such as polynomial chaos expansion. This engine will be embedded in a novel optimisation pipeline where fluences, energies, and orientations are simultaneously optimised with gradient-based algorithms that explicitly account for uncertainties.The project is highly interdisciplinary, positioned at the intersection of medical physics, numerical optimisation, and clinical practice. It involves three world-leading centres: the host institution (UniOvi), under the supervision of Pietro Vischia, an expert in differentiable optimisation and particle physics; a secondment at TU/e on differentiable uncertainty quantification; and a secondment at MAASTRO Clinic for clinical IMPT practice and validation.In summary, PRODIGIO will deliver a significant impact on both the researcher’s career and on cancer care. On the one hand, it will provide extensive multidisciplinary training, placing the researcher in a leading position in the field. On the other, it will deliver the first uncertainty-aware, operator-independent auto-planning system for proton therapy, with the potential to transform radiotherapy treatment planning in Europe and worldwide.

Consortium · 3 organisations

coordinator

UNIVERSIDAD DE OVIEDO

ES · €194,075

associatedPartner

STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC

NL

associatedPartner

TECHNISCHE UNIVERSITEIT EINDHOVEN

NL

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.